Kerry Curran brings a career in medical device technology to a nimble startup leveraging student engineering skill to design products addressing post surgical Pulmonary Atelectasis and Deep Vein Thrombosis (DVT’s). While in it's early stages, this company is demonstrating how creative use of student skill and ingenuity, combined with a strong clinician feedback loop, can lead to useful innovation.
TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and...
